Stockreport

Arrowhead: Gains Make Mockery Of My Sell Call - But Jury May Still Be Out (Rating Upgrade) [Seeking Alpha]

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations
PDF Recent catalysts include a $200M Novartis deal, $300M from Sarepta, and the first commercial approval of plozasiran (Redemplo) for FCS. Despite strong cash inflows an [Read more]